Back
Reliance, Inc. 10K Form
Sell
43
RS
Reliance, Inc.
Last Price:
$299.13
Seasonality Move:
12.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-02 | 10Q | RS/Reliance, Inc. Quarterly |
| 2023-08-03 | 10Q | RS/Reliance, Inc. Quarterly |
| 2023-05-04 | 10Q | RS/Reliance, Inc. Quarterly |
| 2022-11-03 | 10Q | RS/Reliance, Inc. Quarterly |
| 2022-08-04 | 10Q | RS/Reliance, Inc. Quarterly |
| 2022-05-05 | 10Q | RS/Reliance, Inc. Quarterly |
Receive RS News And Ratings
See the #1 stock for the next 7 days that we like better than RS
RS Financial Statistics
Sales & Book Value
| Annual Sales: | $14.3B |
|---|---|
| Cash Flow: | $202.9M |
| Price / Cash Flow: | 31.34 |
| Annual Sales: | $138.59 |
| Price / Book: | 2.15 |
Profitability
| EPS (TTM): | 13.96780 |
|---|---|
| Net Income (TTM): | $741.6M |
| Gross Margin: | $3.8B |
| Return on Equity: | 10.28% |
| Return on Assets: | 7.14% |
Reliance, Inc. Earnings Forecast
Key Reliance, Inc. Financial Ratios
-
The Gross Profit Margin over the past 33 years for RS is 26.87%.
-
The Selling, General & Administrative Expenses for RS have been equal to 19.64% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 7.51% of Operating Income.
-
The Net Earning history of RS is 5.19% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 22 years.
Reliance, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Metals & Mining |
| Sector: | Materials |
| Current Symbol: | RS |
| CUSIP: | 759509 |
| Website: | reliance.com |
Debt
| Debt-to-Equity Ratio: | 0.24 |
|---|---|
| Current Ratio: | 4.88 |
| Quick Ratio: | 2.1 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.3 |
|---|---|
| Forward P/E Ratio: | 15.59 |
RS Technical Analysis vs Fundamental Analysis
Sell
43
Reliance, Inc. (RS)
is a Sell
Is Reliance, Inc. a Buy or a Sell?
-
Reliance, Inc. stock is rated a SellThe current Reliance, Inc. [RS] share price is $297.44. The Score for RS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.